Biosynthesis in nervous tissue
The formation of gamma-aminobutyric acid occurs directly within neurons. The direct and sole precursor of this neurotransmitter is glutamic acid (glutamate).
The process is a decarboxylation reaction (cleavage of a $CO_2$ molecule from the amino acid). This reaction is catalyzed by a specific enzyme — glutamate decarboxylase (GAD). The coenzyme pyridoxal phosphate (PLP), which is the active form of vitamin $B_6$, is absolutely essential for the proper functioning of this enzyme. Any vitamin $B_6$ deficiency inevitably affects the rate of inhibitory neurotransmitter production, leading to the predominance of excitatory processes in the nervous system.
Inactivation and the GABA shunt
After the neurotransmitter has fulfilled its physiological function, it must be inactivated. In biochemistry, this process is known as the GABA shunt. It proceeds in two sequential stages, ensuring not only the utilization of the molecule but also the return of its carbon skeleton to the cell's energy metabolism.
- Transamination. The molecule interacts with $\alpha$-ketoglutarate ($\alpha$-KG). The amino group is transferred to the keto acid, resulting in the formation of succinic semialdehyde and a new glutamate molecule. The reaction is catalyzed by the enzyme GABA transaminase, which, like the synthesis enzyme, is strictly dependent on the coenzyme PLP ($B_6$).
- Oxidation. Succinic semialdehyde undergoes oxidation with the participation of the enzyme succinic semialdehyde dehydrogenase. Ultimately, succinate (succinic acid) is formed, which directly enters the tricarboxylic acid (TCA) cycle for further energy production.
Clinical application and the BBB issue
In medical practice, GABA-based drugs (such as Aminalon or Gamalon) belong to the nootropics group. They are prescribed for pathologies accompanied by sharp, uncontrolled excitation of the cerebral cortex—such as epilepsy, traumatic brain injuries, and strokes, when the delicate balance between inhibition and excitation is disrupted.
The beneficial effects of these drugs include:
- Improvement of general brain tissue metabolism.
- Increased glucose utilization by nerve cells.
- Enhanced respiratory activity of neurons (a potent antihypoxic effect).
An important pharmacokinetic nuance: the GABA molecule itself crosses the blood-brain barrier (BBB) extremely poorly. Therefore, the clinical effect of exogenous (externally administered) acid is most often explained by the indirect improvement of cerebral circulation and peripheral metabolism. For direct action on CNS receptors, pharmacologists have synthesized special derivatives that easily cross the BBB—such as phenibut or picamilon.
Briefly: answers to topical questions
What classes of receptors does GABA act upon in the central nervous system?
In the central nervous system, GABA acts on receptors that are subdivided into several types. The primary example of inhibitory receptors is type A GABA receptors ($GABA_A$ receptors).
- $GABA_A$ receptors are ionotropic receptors that are directly coupled to anion (chloride) channels.
- Other types — sources mention that GABA receptors are subdivided into several types, but only type A is described in detail.
What is the molecular mechanism of inhibitory postsynaptic potential development under the action of GABA?
The molecular mechanism of inhibition is realized via the ionotropic pathway.
Mechanism of action:
- Interaction of GABA with receptor proteins.
- Opening of anion (chloride) channels directly coupled to the receptor.
- Inward flux of negative chloride ions ($Cl^-$) into the postsynaptic cell along the concentration gradient.
- Development of postsynaptic membrane hyperpolarization.
- Enhancement of inhibitory processes (inhibition of the respective cell).
Vitamin B6 is the "key" to inhibition: it is needed both for GABA synthesis (GAD) and for its degradation (transaminase).
Class and exam questions
From which substance is GABA synthesized?
The sole precursor is the amino acid glutamate (glutamic acid).
Which coenzyme is involved in GABA metabolism?
Pyridoxal phosphate (the active form of vitamin B6). It acts as a coenzyme for both glutamate decarboxylase and GABA transaminase.
How is the GABA shunt connected to energy metabolism?
During GABA inactivation, succinic semialdehyde is formed, which is oxidized to succinate. Succinate is a substrate for the tricarboxylic acid (TCA) cycle, where it is oxidized to release energy.
Why are GABA derivatives rather than GABA itself frequently prescribed in stroke management?
Pure acid has very poor permeability across the blood-brain barrier. Derivatives (e.g., phenibut) easily cross the BBB and exert a direct nootropic effect.
What else to study on this topic
- Mechanism of the glutamate decarboxylation reaction
- Specificity of the glutamate decarboxylase (GAD) enzyme
- Role of succinate in the tricarboxylic acid cycle
- Structural features of the blood-brain barrier
- Mechanism of action of nootropic drugs in hypoxia
Master the entire topic in the "Biochemistry" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Gamma-aminobutyric acid" and 3,616 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 115 video lessons on the subject
Other topics in the "Amino acid metabolism" section
Free video lessons: biochemistryShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.